New Drug For Cancer Therapy
Brno - Chemotherapy not only traumatizes patients because of its side effects like nausea but also because its invasive administration via injections. The new cytostatic drug LA-12, developped by Czech scientists at the Brno-based company Pliva Lachema, not only alleviates chemo-therapy's side effects but has less side effects than previously used drugs and can be taken as a pill, too. It could even be effective in cases when chemotherapy fails.
According to Pliva's scientist Petr Sova applications for a patent for LA-12 have been filed in 50 countries, including key markets such as the United States, Japan, Australia and the European countries. The drug is currently undergoing clinical testing and is expected to be available on the market in three to four years' time . Sova's team estimates some $800 million turnover per year. LA-12 contains Adamantan as a special ingredient which is responsible for the drugs' efficacy, says Sova (J. Med. Chem. 2004, Jan 29; 47(3): 761-763).